IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2150 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded90    
    Comments [Add]    
    Cited by others 5    

Recommend this journal


Year : 2014  |  Volume : 46  |  Issue : 3  |  Page : 339-340

Spontaneous rectus sheath hematoma during rivaroxaban therapy

1 Department of Cardiology, Yenikent State Hospital, Turkey
2 Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey
3 Department of Cardiology, Vakfikebir State Hospital, Trabzon, Turkey

Correspondence Address:
Ibrahim Kocayigit
Department of Cardiology, Yenikent State Hospital
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.132193

Rights and Permissions

Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow